The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...
The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. Labcorp Plasma Complete detects ...
"Labcorp Plasma Complete delivers powerful and comprehensive genomic insights and helps guide targeted treatment decisions even when tissue-based testing is not feasible," said Shakti Ramkissoon ...
Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...
Hosted on MSN10mon
Blood test could detect preeclampsia in first trimester, LabCorp reportsLabcorp is in talks with health insurers to see if the test could be covered, Caveney said, adding that it carries a list price of about $240. The test works by measuring four biomarkers ...
The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback